COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025

2020-05-06
Price :
Published : May-2020
No. of Pages : 70

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Research Scope
1.3.1 Segments Covered
1.3.2 Geographic Scope
1.3.3 Years Considered For The Study
1.4 Currency Used For The Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping Market Estimation
2.2.2 Procedure Based Based Market Estimation
2.2.3 Primary Data Validation
2.3 Covid-19 Impact Assessment Methodology
2.4 Research Assumptions
2.5 Research Limitations

3 In Vitro Diagnostics Industry Ecosystem
3.1 Major Technologies
3.2 Key Application Areas
3.3 Prominent End User Categories
3.4 50 Major Global Manufacturers

4 In Vitro Diagnostics: Industry Insights
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 Global Regulatory Scenario
4.3 Global Supply Chain Assessment

5 In Vitro Diagnostics Market Assessment For Covid Impact, By Technology [Usd Million; 2019, 2020 (H1), 2020 (H2), 2021, 2025]
5.1 Polymerase Chain Reaction (Pcr)
5.2 Next Generation Sequencing (Ngs)
5.3 Microarray
5.4 Isothermal Nucleic Acid Amplification (Inaat)
5.5 Enzyme Linked Immunosorbent Assay (Elisa)
5.6 Lateral Flow Assay
5.7 Hematology
5.8 Hemostasis
5.9 Urinanalysis
5.10 Microbial Testing
5.11 Clinical Chemistry
5.12 Other Technologies

6 In Vitro Diagnostics: End User Landscape
6.1 Hospital-Based Laboratories
6.2 Independent Laboratories
6.3 Reference Laboratories
6.4 Point-Of-Care And Self Testing
6.5 Researchers & Academia
6.6 Other End Users

7 In Vitro Diagnostics Market Assessment For Covid Impact, By Country [Usd Million; 2019, 2020 (H1), 2020 (H2), 2021, 2025]
7.1 Us
7.2 Germany
7.3 Uk
7.4 France
7.5 Italy
7.6 Spain
7.7 China
7.8 Japan
7.9 India
7.10 South Korea
7.11 Australia
7.12 Rest Of Americas
7.13 Rest Of Europe
7.14 Rest Of Asia-Pacific
7.15 Middle East And Africa

8 Competitive Landscape
8.1 Overview
8.2 Market Share Of Top 5 Vendors (In Terms Of %Revenue, As Of 2019)
8.3 Product Portfolio Of Major Vendors For Covid Diagnostics
8.4 Recent Strategic Initiatives (During December 2019 – March 2020)
8.4.1 Portfolio Diversification
8.4.2 Investments And Fundings
8.4.3 Product Development Partnerships
8.4.4 Strategic Collaborations

9 Major Industry Use Cases
9.1 In Vitro Diagnostic Vendors
9.2 Adjacent Industry Vendors
9.3 Raw Material And Component Suppliers
9.4 Healthcare Software Providers

Filed in: Diagnostics
Publisher : marketsandmarkets